Peregrine Ventures

About The Fund

Peregrine Ventures is a venture capital firm specializing in investments across various stages of company development, with a particular focus on the healthcare sector. Holding $600 million in assets under management, they aim to foster medical innovation and enhance patient quality of life by supporting life-changing healthcare opportunities. With an investment range from a minimum of $100,000 to a maximum of $5,000,000, their sweet spot for investment is $1,500,000. The firm tackles diverse areas within healthcare, including Software (Web Marketplace SaaS, etc.), BioTech, HealthTech (& Fitness), Medical Devices (& Hospital Services), and Healthcare (& Wellness). Their expertise spans early stage ventures to more mature companies preparing for an M&A or IPO. The specialties of Peregrine Ventures include Early Stage, Seed, Series A, Series B, and Pre-seed investments. As Israel's first dedicated healthcare fund, they bring substantial experience to the table, providing portfolio companies with guidance to build effective business strategies, forge strategic alliances, assemble robust teams, and launch healthcare innovations into the marketplace. The firm operates with a multidisciplinary approach, combining scientific creativity with business, regulatory, and investment strategies to support the life science companies in their portfolio. Peregrine's investment vehicles are diverse, comprising early and mid-stage funds, Peregrine's Incentive Incubator, and Peregrine Growth, aimed at more mature companies. The firm prides itself on its synergetic strategy and close collaboration with entrepreneurs and industry partners to generate groundbreaking medical technologies and bring them to market. It continues to demonstrate a strong track record of success through its active participation in the development stages of companies, leading to significant contributions to the healthcare industry.